Simplex Trading
WHWK

Simplex Trading’s Whitehawk Therapeutics WHWK Stock Holding History

Simplex Trading’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,400
Closed -$13K – 9944
2024
Q4 		$13K Buy
4,400
+3,400
+340% +$7.7K ﹤0.01% 7041
2024
Q3 		$2K Sell
1,000
-100
-9% -$162 ﹤0.01% 8104
2024
Q2 		$1K Buy
+1,100
New +$2.04K ﹤0.01% 8612
2024
Q1 		– Sell
-2,600
Closed -$5K – 10129
2023
Q4 		$5K Buy
+2,600
New +$10.9K ﹤0.01% 7916

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Simplex Trading's WHWK Position: Q4 2025 in Review

Simplex Trading sold out of Whitehawk Therapeutics (WHWK) in Q4 2025, closing a stake of 35 shares — an estimated $80 sold.

Simplex Trading first reported a position in WHWK in Q4 2021 and held it in 10 quarters. The position peaked at $9K in Q4 2023. 48 funds tracked by Wall St. Rank hold WHWK as of Q4 2025.

  • Simplex Trading reported no remaining Whitehawk Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 35 Whitehawk Therapeutics shares in Q4 2025, an estimated $80.
  • Simplex Trading first reported a position in Whitehawk Therapeutics in Q4 2021 and held it in 10 quarters.
  • Simplex Trading's Whitehawk Therapeutics position peaked at $9K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.